Published source snapshot
Lipo6 Black Intense Ultra Concentrate
Nutrex Research UltraFit Series · US label facts
Label IDlbl_dsld_176133_a5a70509788142c0
Serving size1 Black-Cap(s)
Serving formBlack-Cap(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.
Original facts and normalized results
| Ingredient | Original label quantity | Requested normalization | Measurement object |
|---|---|---|---|
| Blend (Combination) DSLD row path: root.0; DSLD ingredientId: 195830 | 653.5 mg | 653.5 mg / as_labeled | Intense Ultra Concentrated Fat Burner |
| N-Acetyl Tyrosine Source unit marker NP means quantity not provided; source numeric placeholder withheld; DSLD row path: root.0.nested.0; DSLD ingredientId: 7514 | Not stated | missing_quantity | N-Acetyl-L-Tyrosine |
| Caffeine Source unit marker NP means quantity not provided; source numeric placeholder withheld; DSLD row path: root.0.nested.1; DSLD ingredientId: 64541 | Not stated | missing_quantity | Caffeine Citrate |
| Theacrine Source unit marker NP means quantity not provided; source numeric placeholder withheld; DSLD row path: root.0.nested.2; DSLD ingredientId: 135863 | Not stated | missing_quantity | Theacrine |
| Caffeine Source unit marker NP means quantity not provided; source numeric placeholder withheld; DSLD row path: root.0.nested.3; DSLD ingredientId: 4853 | Not stated | missing_quantity | Caffeine Anhydrous |
| Bitter orange Advantra Z Citrus aurantium (Form: 50% P-Synephrine) Genus: Citrus Species: aurantium; Source unit marker NP means quantity not provided; source numeric placeholder withheld; DSLD row path: root.0.nested.4; DSLD ingredientId: 131413 | Not stated | missing_quantity | Advantra Z Citrus aurantium |
| Yohimbine Source unit marker NP means quantity not provided; source numeric placeholder withheld; DSLD row path: root.0.nested.5; DSLD ingredientId: 6933 | Not stated | missing_quantity | Yohimbine HCl |
| Rauwolscine Source unit marker NP means quantity not provided; source numeric placeholder withheld; DSLD row path: root.0.nested.6; DSLD ingredientId: 33625 | Not stated | missing_quantity | Rauwolscine |
| Hypromellose Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 89856. | Not stated | missing_quantity | Hypromellose |
| Cellulose Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 4058. | Not stated | missing_quantity | Microcrystalline Cellulose |
| Magnesium Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 4048. | Not stated | missing_quantity | Magnesium Stearate |
| Silicon Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 293311. | Not stated | missing_quantity | Silica |
| Color Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 4938. | Not stated | missing_quantity | FD&C Blue 1 |
| Color Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 4939. | Not stated | missing_quantity | FD&C Red 40 |
Label statements
These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.
- label_claim Brand IP Statement(s) re: (c), (TM), (SM): TeaCrine is a registered trademark and protected by Patents Pending, Serial No. 61/903.362; Under exclusive global distribution by Compound Solutions, Inc. Advantra Z is a registered trademark of Nutratech, Inc/Zhishin, LLC licensor of U.S. and Canadian Patents.
- label_claim Precautions re: All Other: Never exceed 1 black-cap per serving. Never take more than 2 servings in a 24-hour period.
- label_claim Precautions re: Pregnant or Nursing or Prescription Medications: Do not consume synephrine, yohimbine, caffeine or thyroid-boosting compounds from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine or any stimulants whatsoever.
- label_claim Suggested/Recommended/Usage/Directions: One pill only
- label_claim Precautions re: Children: Warning: Important Must Read: Lipo-6 Black Intense Ultra Concentrate is absolutely not for use by persons under the age of 18 or those sensitive to caffeine.
- label_claim Precautions re: Pregnant or Nursing or Prescription Medications: Consult your physician prior to use if you are taking medication, including but not limited to, MAOI inhibitors, anti-depressants, asprin, non-steroidal anti-inflammatory drugs or products containing phenylephrine, ephedrine, pseudoephedrine, phenylethylamine or other stimulants.
- label_claim FDA Statement of Identity: Dietary Supplement
- label_claim General Statements: All Other Content: Lipo-6 Black Intense Ultra Concentrate take fat burning to the absolute extreme. Its effects are intense. They can be felt in minutes and are long-lasting. Just one pill will give you the strongest weight loss support, intense energy and maximum appetite control.
- label_claim Precautions re: Pregnant or Nursing or Prescription Medications: Do not use if pregnant or nursing.
- label_claim FDA Disclaimer Statement: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- label_claim Formula re: Contains: This product contains caffeine.
- label_claim Formulation re: Does NOT Contain: This product utilizes only natural vegetable capsules that are free of animal products.
- label_claim Precautions re: All Other: Never exceed the maximum dosage.
- label_claim General Statements: All Other Content: Regular exercise and proper nutrition are essential for achieving your weight loss goals. As individuals vary so may results from using this product. This product utilizes a combination of synthetic and natural compounds.
- label_claim Precautions re: Children: Keep out of reach of children.
- label_claim General Statements: All Other Content: Intense fat burner
- label_claim Precautions re: All Other: This product contains caffeine. Do not use this product for longer than 2 months. Follow with a 30 day break.
- label_claim Precautions re: All Other: Do not take within 6 hours of sleep.
- label_claim Precautions re: All Other: Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney or thyroid disease, psychiatric disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue use 2 weeks prior to surgery. Immediately discontinue if you experience rapid heartbeat, dizziness, severe headaches or shortness of breath. This product contains ingredients that may be banned by some sports organizations.
- label_claim Suggested/Recommended/Usage/Directions: Recommended Use: Due to the intense nature of this product all guidelines should be strictly adhered to. Take 1 black-cap in the morning and 1 black-cap in the afternoon. Never exceed 1 black-cap per serving. Never take more than 2 servings in a 24-hour period. For best results do not take with food. Consume at least 45 minutes before a meal. Do not take within 6 hours of sleep.
- label_claim General: Product/Version Code: LBL-LIPO6BLKINTENSEUC-60CT-V1-US
Ingredient references
Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.
- Blend (Combination) reference index
- N-Acetyl Tyrosine reference index
- Caffeine reference index
- Theacrine reference index
- Caffeine reference index
- Bitter orange reference index
- Yohimbine reference index
- Rauwolscine reference index
- Hypromellose reference index
- Cellulose reference index
- Magnesium reference index
- Silicon reference index
Source and version
- Original record
- NIH ODS DSLD label 176133
- Local snapshot
- snap_dsld_176133_a5a70509788142c03ccbf5a8
- Content hash
a5a70509788142c03ccbf5a8eee366fc33edb0b13c3c049716dd41fecfed4e0e- Source version
- LBL-LIPO6BLKINTENSEUC-60CT-V1-US
Limitations
- This record reports label facts from a US-market source snapshot, not current inventory or product safety.
- Label quantity comparisons do not establish absorption, efficacy, safety, or clinical equivalence.